Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide derived from the C-terminal end of the mouse ephrin-A4 protein|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|Immunohistochemistry (IHC)||Assay Dependent|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 1 publications below|
Ephrin A4 (the antigen to this antibody) is also known as LERK-4 or ELF-4. Ephrin-A4 binds EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, and EphB1. To date, at least 14 members of the Eph receptor family and a family of 8 ligands have been identified. Ligands of Eph family receptors are structurally related membrane-bound proteins that can be subdivided into two major subclasses: ephrin-A and ephrin-B. Ligands in the ephrin-A subclass, including the prototype family member ephrin-A1 (B61), are membrane associated through glycosylphosphatidyl-inositollinkages; whereas ephrin-B subclass consists of ligands with transmembrane domains.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Human||Not Cited||Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.||Vincent A,Omura N,Hong SM,Jaffe A,Eshleman J,Goggins M||Clinical cancer research : an official journal of the American Association for Cancer Research (17:4341)||2011|
EFL4; EPH-related receptor tyrosine kinase ligand 4; ephrin-A4; EPLG4; LERK-4; LERK4; ligand of eph-related kinase 4
EFL-4; EFL4; EFNA4; Epl4; EPLG4; LERK-4; LERK4